Molecular Surveillance for Drug-Resistant Malaria in Cambodia
Author Information
Author(s): Naman K. Shah, Alisa P. Alker, Rithy Sem, Ika Susanti Agustina, Sinuon Muth, Jason D. Maguire, Socheat Duong, Frederic Ariey, Steven R. Meshnick, Chansuda Wongsrichanalai
Primary Institution: University of North Carolina School of Public Health
Hypothesis
Is there a geographic variation in the prevalence of multidrug-resistant Plasmodium falciparum in Cambodia?
Conclusion
The study found that western Cambodia has a higher prevalence of multidrug-resistant P. falciparum compared to eastern Cambodia.
Supporting Evidence
- Western Cambodia has a higher prevalence of pfmdr1 gene copies associated with drug resistance.
- Geographic variation in drug resistance suggests the need for targeted surveillance.
- Clinical trials were launched based on the findings of increased drug resistance in specific areas.
Takeaway
This study looked at malaria in Cambodia and found that some areas have more drug-resistant malaria than others, which is important for treating patients.
Methodology
The study collected clinical isolates from 5 sites in Cambodia and assessed molecular changes in the pfmdr1 gene.
Potential Biases
Potential bias due to the geographic focus on specific sites and the reliance on molecular markers for resistance.
Limitations
The study was limited by the resource-intensive nature of in vivo studies and the small number of sites that could be monitored each year.
Participant Demographics
Participants included patients with uncomplicated falciparum malaria from various health centers across Cambodia.
Statistical Information
P-Value
0.139
Confidence Interval
95% CI 10.3–25.3
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website